MC-Val-Ala-PAB-PNP

MC-Val-Ala-PAB-PNP, also known as 4-(4-nitrophenoxy)butanoic acid-p-aminobenzyl-valyl-alanyl-methylcarbamate, is a specialized carbohydrate-based linker frequently utilized in biochemical research and drug discovery. This compound features a distinct self-immolative structure, making it particularly valuable for the controlled release of active agents in response to specific enzymatic triggers. Its modular design incorporates a dipeptide sequence (valine-alanine) and a para-aminobenzyl (PAB) spacer, which together facilitate enzymatic recognition and subsequent release mechanisms. The inclusion of a para-nitrophenoxy (PNP) group further enhances its utility, allowing for sensitive detection and quantification of enzymatic activity. Researchers value MC-Val-Ala-PAB-PNP for its versatility, stability under physiological conditions, and its ability to be incorporated into a wide range of molecular constructs for targeted delivery and diagnostic applications.

Enzyme Substrate Assays: MC-Val-Ala-PAB-PNP is widely employed in the development of enzyme substrate assays, particularly for proteases that recognize the valine-alanine sequence. Upon enzymatic cleavage, the self-immolative linker undergoes a cascade reaction, resulting in the release of the PNP moiety. This release can be monitored spectrophotometrically due to the chromogenic properties of PNP, enabling researchers to quantitatively assess protease activity in complex biological samples. The modularity of this substrate system allows for customization to match the specificity of various enzymes, making it a powerful tool in enzymology and high-throughput screening workflows.

Targeted Prodrug Design: The unique self-immolative mechanism of this linker makes it an attractive component in the design of targeted prodrugs. By conjugating therapeutic agents to MC-Val-Ala-PAB-PNP, researchers can engineer prodrugs that remain inactive until encountering specific enzymatic activity within a desired biological environment. The selective cleavage of the dipeptide segment triggers a rapid and efficient release of the active drug, minimizing off-target effects and improving therapeutic index. This approach is particularly valuable in the development of precision medicines where spatial and temporal control over drug activation is crucial.

Diagnostic Imaging Probes: MC-Val-Ala-PAB-PNP is also utilized in the synthesis of diagnostic imaging probes. By attaching imaging agents such as fluorophores or radionuclides to the linker, scientists can create probes that are activated only in the presence of targeted enzymatic activity. The release of the imaging agent following enzymatic cleavage provides a highly specific readout, enhancing the sensitivity and accuracy of molecular imaging techniques. This strategy is instrumental in visualizing disease-associated enzyme activity in preclinical research and in the validation of novel diagnostic targets.

Enzyme Inhibitor Screening: The compound serves as a valuable substrate in enzyme inhibitor screening assays. By incorporating it into assay systems, researchers can evaluate the efficacy of candidate inhibitors by measuring their ability to block the enzymatic cleavage and subsequent release of the PNP chromophore. This provides a rapid and quantitative method for identifying potent inhibitors, supporting the discovery and optimization of new therapeutic agents targeting proteolytic enzymes.

Chemical Biology Tool Development: MC-Val-Ala-PAB-PNP enables the creation of innovative chemical biology tools for probing enzyme function and cellular processes. Its self-immolative linker system can be adapted to deliver a variety of molecular payloads, including affinity tags, reporter molecules, or bioactive compounds, in response to specific enzymatic cues. This versatility makes it an essential building block for the development of biosensors, activity-based probes, and other research tools that advance our understanding of enzymatic pathways and cellular signaling networks. By integrating this compound into experimental systems, scientists can achieve precise control over molecular release events, facilitating novel approaches in chemical biology and functional genomics research.

1. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

2. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

4. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

5. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry